| Year |
Citation |
Score |
| 2023 |
Swanner J, Shim JS, Rivera-Caraballo KA, Vázquez-Arreguín K, Hong B, Bueso-Perez AJ, Lee TJ, Banasavadi-Siddegowda YK, Kaur B, Yoo JY. esRAGE-expressing oHSV enhances anti-tumor efficacy by inhibition of endothelial cell activation. Molecular Therapy Oncolytics. 28: 171-181. PMID 36789106 DOI: 10.1016/j.omto.2023.01.003 |
0.548 |
|
| 2022 |
Hwang B, Gho Y, Kim H, Lee S, Hong SA, Lee TJ, Myung SC, Yun SJ, Choi YH, Kim WJ, Moon SK. Petal Extract Exhibits Antitumor Effects by Abrogating Tumor Progression and Angiogenesis in Bladder Cancer Both In Vivo and In Vitro. Integrative Cancer Therapies. 21: 15347354221114337. PMID 35912937 DOI: 10.1177/15347354221114337 |
0.363 |
|
| 2022 |
Banasavadi-Siddegowda YK, Namagiri S, Otani Y, Sur H, Rivas S, Bryant JP, Shellbourn A, Rock M, Chowdhury A, Lewis CT, Shimizu T, Walbridge S, Kumarasamy S, Shah AH, Lee TJ, et al. Targeting protein arginine methyltransferase 5 sensitizes glioblastoma to trametinib. Neuro-Oncology Advances. 4: vdac095. PMID 35875691 DOI: 10.1093/noajnl/vdac095 |
0.52 |
|
| 2022 |
Rivera-Caraballo KA, Nair M, Lee TJ, Kaur B, Yoo JY. The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeutics. Molecular Therapy Oncolytics. 26: 63-75. PMID 35795093 DOI: 10.1016/j.omto.2022.05.013 |
0.532 |
|
| 2022 |
Nguyen QTT, Park HS, Lee TJ, Choi KM, Park JY, Kim D, Kim JH, Park J, Lee EJ. DKK3, Downregulated in Invasive Epithelial Ovarian Cancer, Is Associated with Chemoresistance and Enhanced Paclitaxel Susceptibility via Inhibition of the β-Catenin-P-Glycoprotein Signaling Pathway. Cancers. 14. PMID 35205672 DOI: 10.3390/cancers14040924 |
0.306 |
|
| 2021 |
Nair M, Bolyard C, Lee TJ, Kaur B, Yoo JY. Therapeutic Application of Brain-Specific Angiogenesis Inhibitor 1 for Cancer Therapy. Cancers. 13. PMID 34298774 DOI: 10.3390/cancers13143562 |
0.567 |
|
| 2021 |
Yeh M, Wang YY, Yoo JY, Oh C, Otani Y, Kang JM, Park ES, Kim E, Chung S, Jeon YJ, Calin GA, Kaur B, Zhao Z, Lee TJ. MicroRNA-138 suppresses glioblastoma proliferation through downregulation of CD44. Scientific Reports. 11: 9219. PMID 33911148 DOI: 10.1038/s41598-021-88615-8 |
0.516 |
|
| 2021 |
Park ES, Kim S, Huang S, Yoo JY, Körbelin J, Lee TJ, Kaur B, Dash PK, Chen PR, Kim E. Selective endothelial hyperactivation of oncogenic KRAS induces brain arteriovenous malformations in mice. Annals of Neurology. PMID 33675084 DOI: 10.1002/ana.26059 |
0.424 |
|
| 2020 |
Yoo JY, Yeh M, Kaur B, Lee TJ. Targeted delivery of small noncoding RNA for glioblastoma. Cancer Letters. PMID 33176185 DOI: 10.1016/j.canlet.2020.11.004 |
0.498 |
|
| 2020 |
Lee TJ, Yuan X, Kerr K, Yoo JY, Kim DH, Kaur B, Eltzschig HK. Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury. Pharmacological Reviews. 72: 639-667. PMID 32554488 DOI: 10.1124/Pr.119.019026 |
0.444 |
|
| 2020 |
Nair M, Khosla M, Otani Y, Yeh M, Park F, Shimizu T, Kang JM, Bolyard C, Yu JG, Kumar Banasavadi-Siddegowda Y, Lopez G, Kaur B, Pollock RE, Lee TJ, Old M, et al. Enhancing Antitumor Efficacy of Heavily Vascularized Tumors by RAMBO Virus through Decreased Tumor Endothelial Cell Activation. Cancers. 12. PMID 32340193 DOI: 10.3390/Cancers12041040 |
0.562 |
|
| 2020 |
Otani Y, Yoo JY, Chao S, Liu J, Jaime-Ramirez AC, Lee TJ, Hurwitz B, Yan Y, Dai H, Glorioso JC, Caligiuri MA, Yu J, Kaur B. Oncolytic HSV infected glioma cells activate NOTCH in adjacent tumor cells sensitizing tumors to gamma secretase inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32139403 DOI: 10.1158/1078-0432.Ccr-19-3420 |
0.548 |
|
| 2019 |
Yeh M, Oh CS, Yoo JY, Kaur B, Lee TJ. Pivotal role of microRNA-138 in human cancers. American Journal of Cancer Research. 9: 1118-1126. PMID 31285946 |
0.512 |
|
| 2019 |
Yoo JY, Swanner J, Otani Y, Nair M, Park F, Banasavadi-Siddegowda Y, Liu J, Jaime-Ramirez AC, Hong B, Geng F, Guo D, Bystry D, Pelphs M, Quadri H, Lee TJ, et al. oHSV therapy increases trametinib access to brain tumors and sensitizes them in vivo. Neuro-Oncology. PMID 31063549 DOI: 10.1093/Neuonc/Noz079 |
0.543 |
|
| 2019 |
Lee TJ, Nair M, Banasavadi-Siddegowda YK, Liu J, Nallanagulagari T, Jaime-Ramirez AC, Guo JY, Quadri H, Zhang J, Bockhorst KH, Aghi MK, Carbonell WS, Kaur B, Yoo JY. Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus-1 with Integrin β1 Blocking Antibody OS2966. Molecular Cancer Therapeutics. PMID 30926634 DOI: 10.1158/1535-7163.Mct-18-0953 |
0.563 |
|
| 2019 |
Hong B, Muili K, Bolyard C, Russell L, Lee TJ, Banasavadi-Siddegowda Y, Yoo JY, Yan Y, Ballester LY, Bockhorst KH, Kaur B. Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema. Molecular Therapy Oncolytics. 12: 93-102. PMID 30719499 DOI: 10.1016/J.Omto.2018.11.005 |
0.535 |
|
| 2018 |
Yu JW, Bhattacharya S, Yanamandra N, Kilian D, Shi H, Yadavilli S, Katlinskaya Y, Kaczynski H, Conner M, Benson W, Hahn A, Seestaller-Wehr L, Bi M, Vitali NJ, Tsvetkov L, ... ... Lee T, et al. Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments. Plos One. 13: e0206223. PMID 30388137 DOI: 10.1371/Journal.Pone.0206223 |
0.336 |
|
| 2018 |
Kim Y, Yoo JY, Lee TJ, Liu J, Yu J, Caligiuri MA, Kaur B, Friedman A. Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 29686060 DOI: 10.1073/Pnas.1715295115 |
0.537 |
|
| 2017 |
Jaime-Ramirez AC, Yu JG, Caserta E, Yoo JY, Zhang J, Lee TJ, Hofmeister C, Lee JH, Kumar B, Pan Q, Kumar P, Baiocchi R, Teknos T, Pichiorri F, Kaur B, et al. Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma. Molecular Therapy Oncolytics. 5: 87-96. PMID 28812060 DOI: 10.1016/J.Omto.2017.05.002 |
0.536 |
|
| 2017 |
Lee TJ, Yoo JY, Shu D, Li H, Zhang J, Yu JG, Jaime-Ramirez AC, Acunzo M, Romano G, Cui R, Sun HL, Luo Z, Old M, Kaur B, Guo P, et al. RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28109960 DOI: 10.1016/J.Ymthe.2016.11.016 |
0.494 |
|
| 2016 |
Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai H, Nallanagulagari T, Wojton J, Hurwitz B, Relation T, Yu JG, Lee TJ, Lotze MT, Zhang J, Croce CM, Yu J, Caligiuri MA, et al. Bortezomib treatment sensitizes oncolytic HSV-1 treated tumors to NK cell immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27390350 DOI: 10.1158/1078-0432.Ccr-16-1003 |
0.546 |
|
| 2015 |
Lee TJ, Haque F, Vieweger M, Yoo JY, Kaur B, Guo P, Croce CM. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor. Methods in Molecular Biology (Clifton, N.J.). 1297: 137-52. PMID 25896001 DOI: 10.1007/978-1-4939-2562-9_10 |
0.481 |
|
| 2015 |
Lee TJ, Haque F, Shu D, Yoo JY, Li H, Yokel RA, Horbinski C, Kim TH, Kim SH, Kwon CH, Nakano I, Kaur B, Guo P, Croce CM. RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model. Oncotarget. 6: 14766-76. PMID 25885522 DOI: 10.18632/Oncotarget.3632 |
0.533 |
|
| 2012 |
Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, Kim T, Bakà cs A, Alder H, Kaur B, Aqeilan RI, Pichiorri F, Croce CM. MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proceedings of the National Academy of Sciences of the United States of America. 109: 5316-21. PMID 22431589 DOI: 10.1073/Pnas.1202465109 |
0.466 |
|
| 2009 |
Park SM, Kim K, Lee EJ, Kim BK, Lee TJ, Seo T, Jang IS, Lee SH, Kim S, Lee JH, Park J. Reduced expression of DRAM2/TMEM77 in tumor cells interferes with cell death. Biochemical and Biophysical Research Communications. 390: 1340-4. PMID 19895784 DOI: 10.1016/J.Bbrc.2009.10.149 |
0.314 |
|
| Show low-probability matches. |